![Michele Hill-Perkins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michele Hill-Perkins
Directeur/Membre du Conseil chez Stealthyx Therapeutics Ltd.
Profil
Michele Hill-Perkins is currently a Director at Stealthyx Therapeutics Ltd.
She previously worked as a Project Director at Partnerships UK Ltd., a Non-Executive Director at Activiomics Ltd., a Principal at The Wellcome Trust Ltd., a Principal at Cancer Research Technology Ltd., and a Senior Manager-Technology Transfer at Queen Mary Innovation Ltd.
Hill-Perkins received her undergraduate, graduate, and doctorate degrees from University College London.
Postes actifs de Michele Hill-Perkins
Sociétés | Poste | Début |
---|---|---|
Stealthyx Therapeutics Ltd.
![]() Stealthyx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Stealthyx Therapeutics Ltd. operates drug delivery system technology. The company was founded by Yuti Chernajovsky and Eileen Janis Anderson in 2002 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michele Hill-Perkins
Sociétés | Poste | Fin |
---|---|---|
Queen Mary Innovation Ltd. | Corporate Officer/Principal | - |
The Wellcome Trust Ltd.
![]() The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Corporate Officer/Principal | - |
Cancer Research Technology Ltd.
![]() Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Partnerships UK Ltd. | Corporate Officer/Principal | - |
Activiomics Ltd.
![]() Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Formation de Michele Hill-Perkins
University College London | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 6 |
---|---|
Activiomics Ltd.
![]() Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Commercial Services |
Cancer Research Technology Ltd.
![]() Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
Partnerships UK Ltd. | Finance |
The Wellcome Trust Ltd.
![]() The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
Queen Mary Innovation Ltd. | |
Stealthyx Therapeutics Ltd.
![]() Stealthyx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Stealthyx Therapeutics Ltd. operates drug delivery system technology. The company was founded by Yuti Chernajovsky and Eileen Janis Anderson in 2002 and is headquartered in London, the United Kingdom. | Health Technology |